The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and rhoa signaling in breast cancer

Molecular Cancer Research

Volumn 12, Issue 1, 2014, Pages 130-142

  Hauser, Andrew D ^a,b   Bergom, Carmen ^a,b   Schuld, Nathan J ^a,b   Chen, Xiuxu ^a,b   Lorimer, Ellen L ^a,b   Huang, Jian ^a,b   Mackinnon, Alexander C ^a,b   Williams, Carol L ^a,b  

^a Cancer Center   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN VARIANT; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RNA; SHORT HAIRPIN RNA; SMGGDS 558 PROTEIN; SMGGDS 607 PROTEIN; SMGGDS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; TISSUE MICROARRAY; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; KAPLAN-MEIER ESTIMATE; MCF-7 CELLS; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NF-KAPPA B; PROGNOSIS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN TRANSPORT; RHO GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; RNA SPLICING; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS;

EID: 84893101773     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-13-0362     Document Type: Article

References (40)

1. Bellizzi A, Mangia A, Chiriatti A, Petroni S, Quaranta M, Schittulli F, et al. RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease. Int J Mol Med 2008;22:25-31.
2. Pille JY, Denoyelle C, Varet J, Bertrand JR, Soria J, Opolon P, et al. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther 2005;11:267-74.
3. Wu M, Wu ZF, Rosenthal DT, Rhee EM, Merajver SD. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers. Cancer 2010;116(11 Suppl):2768-82.
4. Weigelt B, Peterse JL, van 't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005;5:591-602.
5. Montaner S, Perona R, Saniger L, Lacal JC. Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the rho family of GTPases. J Biol Chem 1998;273:12779-85.
6. Del Re DP, Miyamoto S, Brown JH. Focal adhesion kinase as a RhoAactivable signaling scaffold mediating akt activation and cardiomyocyte protection. J Biol Chem 2008;283:35622-9.
7. Denoyelle C, Vasse M, Korner M, Mishal Z, Ganne F, Vannier JP, et al. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study. Carcinogenesis 2001;22:1139-48.
8. Tapia MA, Gonzalez-Navarrete I, Dalmases A, Bosch M, Rodriguez-Fanjul V, Rolfe M, et al. Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin. Cell Cycle 2007;6:2284-92.
9. Montagut C, Tusquets I, Ferrer B, Corominas JM, Bellosillo B, Campas C, et al. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocr Relat Cancer 2006;13:607-16.
10. Mizuno T, Kaibuchi K, Yamamoto T, Kawamura M, Sakoda T, Fujioka H, et al. A stimulatory GDP/GTP exchange protein for smg p21 is active on the post-translationally processed form of c-ki-ras p21 and rhoA p21. Proc Natl Acad Sci U S A 1991;88:6442-6.
11. Hiraoka K, Kaibuchi K, Ando S, Musha T, Takaishi K, Mizuno T, et al. Both stimulatory and inhibitory GDP/GTP exchange proteins, smg GDS and rho GDI, are active on multiple small GTP-binding proteins. Biochem Biophys Res Commun 1992;182:921-30.
12. Orita S, Kaibuchi K, Kuroda S, Shimizu K, Nakanishi H, Takai Y. Comparison of kinetic properties between two mammalian ras p21 GDP/GTP exchange proteins, ras guanine nucleotide-releasing factor and smg GDP dissociation stimulation. J Biol Chem 1993; 268:25542-6.
13. Yaku H, Sasaki T, Takai Y. The dbl oncogene product as a GDP/GTP exchange protein for the rho family: its properties in comparison with those of smg GDS. Biochem Biophys Res Commun 1994;198: 811-7.
14. Strassheim D, Porter RA, Phelps SH, Williams CL. Unique in vivo associations with SmgGDS and RhoGDI and different guanine nucleotide exchange activities exhibited by RhoA, dominant negative RhoA(asn-19), and activated RhoA(val-14). J Biol Chem 2000;275: 6699-702.
15. Hamel B, Monaghan-Benson E, Rojas RJ, Temple BR, Marston DJ, Burridge K, et al. SmgGDS is a guanine nucleotide exchange factor that specifically activates RhoA and RhoC. J Biol Chem 2011;286: 12141-8.
16. Williams CL. The polybasic region of ras and rho family small GTPases: a regulator of protein interactions and membrane association and a site of nuclear localization signal sequences. Cell Signal 2003;15:1071-80.
17. Berg TJ, Gastonguay AJ, Lorimer EL, Kuhnmuench JR, Li R, Fields AP, et al. Splice variants of SmgGDS control small GTPase prenylation and membrane localization. J Biol Chem 2010;285:35255-66.
18. Zhi H, Yang XJ, Kuhnmuench J, Berg T, Thill R, Yang H, et al. SmgGDS is up-regulated in prostate carcinoma and promotes tumour phenotypes in prostate cancer cells. J Pathol 2009;217:389-97.
19. Ma PC, Tretiakova MS, MacKinnon AC, Ramnath N, Johnson C, Dietrich S, et al. Expression and mutational analysis of MET in human solid cancers. Genes Chromosomes Cancer 2008;47:1025-37.
20. Brenton JD, Carey LA, Ahmed AA, Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 2005;23:7350-60.
21. Lanning CC, Daddona JL, Ruiz-Velasco R, Shafer SH, Williams CL. The Rac1 C-terminal polybasic region regulates the nuclear localization and protein degradation of Rac1. J Biol Chem 2004;279:44197-210.
22. Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671-5.
23. Strassheim D, Shafer SH, Phelps SH, Williams CL. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma. Cancer Res 2000;60:2730-6.
24. LanningCC, Ruiz-Velasco R, Williams CL. Novel mechanism of the coregulation of nuclear transport of SmgGDS and Rac1. J Biol Chem 2003;278:12495-506.
25. Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 2010;123:725-31.
26. Tew GW, Lorimer EL, Berg TJ, Zhi H, Li R, Williams CL. SmgGDS regulates cell proliferation, migration, and NF-kappaB transcriptional activity in non-small cell lung carcinoma. J Biol Chem 2008;283: 963-76.
27. van Golen KL,Wu ZF, Qiao XT, Bao LW, Merajver SD. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 2000;60:5832-8.
28. Gianni L, Zambetti M, Clark K, Baker J, Cronin M, Wu J, et al. Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer. J Clin Oncol 2005;23:7265-77.
29. Starcevic SL, Diotte NM, Zukowski KL, Cameron MJ, Novak RF. Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD). Toxicol Sci 2003;75:74-81.
30. Ghosh A, Akech J, Mukherjee S, Das SK. Differential expression of cholinephosphotransferase in normal and cancerous human mammary epithelial cells. Biochem Biophys Res Commun 2002;297:1043-8.
31. McHenry PR, Vargo-Gogola T. Pleiotropic functions of rho GTPase signaling: a trojan horse or achilles' heel for breast cancer treatment? Curr Drug Targets 2010;11:1043-58.
32. Liao YC, Ruan JW, Lua I, Li MH, Chen WL, Wang JR, et al. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling. Oncogene 2012;31: 3086-97.
33. Wu D, Asiedu M, Wei Q. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.Oncogene 2009;28: 2219-30.
34. Benitah SA, Valeron PF, van Aelst L, Marshall CJ, Lacal JC. Rho GTPases in human cancer: An unresolved link to upstream and downstream transcriptional regulation. Biochim Biophys Acta 2004; 1705:121-32.
35. Pruitt K, Der CJ. Ras and rho regulation of the cell cycle and oncogenesis. Cancer Lett 2001;171:1-10.
36. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002;2:133-42.
37. Frost JA, Swantek JL, Stippec S, Yin MJ, Gaynor R, Cobb MH. Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1. J Biol Chem 2000;275:19693-9.
38. Tobar N, Caceres M, Santibanez JF, Smith PC, Martinez J. RAC1 activity and intracellular ROS modulate the migratory potential of MCF-7 cells through a NADPH oxidase and NFkappaB-dependent mechanism. Cancer Lett 2008;267:125-32.
39. Gastonguay A, Berg T, Hauser AD, Schuld N, Lorimer E, Williams CL. The role of Rac1 in the regulation of NF-kappaB activity, cell proliferation, and cell migration in non-small cell lung carcinoma. Cancer Biol Ther 2012;13:647-56.
40. Wu M, Wu ZF, Kumar-Sinha C, Chinnaiyan A, Merajver SD. RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells. Breast Cancer Res Treat 2004; 84:3-12.